ArticleThe plant pathology journal2026
Secondary Metabolites from the Marine-Derived Fungus Aspergillus udagawae SFC20170619-M03 Exhibiting Disease Control Activity.
Article in The plant pathology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In our screening program for novel biocontrol agents, we found that the culture filtrate of the marine-derived fungus Aspergillus udagawae SFC20170619-M03 exhibited disease control activity against several fungal plant diseases, including tomato gray mold, tomato late blight, and pepper anthracnose. Bioassay-guided fractionation of the active extracts led to the isolation of sixteen secondary metabolites, comprising nine xanthones (1-9), three benzoquinones (10-12), three spirocyclic furanone lactams (13-15), and one polyene (16). Among these compounds, the xanthone derivative MS-347a (1), a principal bioactive metabolite of A. udagawae SFC20170619-M03, exhibited promising antifungal and antibacterial activities, with minimum inhibitory concentrations ranging from 3.2 to 100 μg/mL. In planta assays further demonstrated that MS-347a (1) effectively suppressed tomato gray mold, tomato late blight, and pepper anthracnose, with control efficacies from 55% to 94% at a concentration of 62.5 μg/mL. The nonepoxidized xanthone AGI-B4 (7) exhibited potent and selective anti-oomycete activity against Phytophthora infestans, with a control efficacy of 91% against tomato late blight at 500 μg/mL. The benzoquinone derivative fumigatin (10) exhibited relatively weaker but broaderspectrum antimicrobial activity in vitro and provided moderate suppression of tomato gray mold in vivo. Taken together, these findings suggest that A. udagawae SFC20170619-M03 and its bioactive metabolites represent promising resources for the development of environmentally sustainable biocontrol agents for agricultural applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.